These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 11987523

  • 21. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 22. [Adverse drug effects observed at French admissions departments and emergency services (Prospective study of the National Educational Association for Teaching Therapeutics and proposals for preventive measures].
    Queneau P, Bannwarth B, Carpentier F, Guliana JM, Bouget J, Trombert B, Leverve X, Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique.
    Bull Acad Natl Med; 2003 Jan; 187(4):647-66; discussion 666-70. PubMed ID: 14556474
    [Abstract] [Full Text] [Related]

  • 23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 24. Renal vulnerability to drug toxicity.
    Perazella MA.
    Clin J Am Soc Nephrol; 2009 Jul; 4(7):1275-83. PubMed ID: 19520747
    [Abstract] [Full Text] [Related]

  • 25. [Drug-induced nephrotoxicity: bibliography from January 2003 to December 2004].
    Karie S, Launay-Vacher V, Izzedine H, Deray G.
    Nephrol Ther; 2005 Nov; 1(5):285-95. PubMed ID: 16895697
    [Abstract] [Full Text] [Related]

  • 26. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
    [Abstract] [Full Text] [Related]

  • 27. Use of renal risk drugs in hospitalized patients with impaired renal function--an underestimated problem?
    Blix HS, Viktil KK, Moger TA, Reikvam A.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3164-71. PubMed ID: 16880181
    [Abstract] [Full Text] [Related]

  • 28. The future of antihypertensive treatment.
    Israili ZH, Hernández-Hernández R, Valasco M.
    Am J Ther; 2007 Nov; 14(2):121-34. PubMed ID: 17414579
    [Abstract] [Full Text] [Related]

  • 29. Drug-induced nephrotoxicity.
    Naughton CA.
    Am Fam Physician; 2008 Sep 15; 78(6):743-50. PubMed ID: 18819242
    [Abstract] [Full Text] [Related]

  • 30. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1997 Apr 15; 450():1-321. PubMed ID: 12594525
    [Abstract] [Full Text] [Related]

  • 31. Zoledronic Acid and renal toxicity: data from French adverse effect reporting database.
    Munier A, Gras V, Andrejak M, Bernard N, Jean-Pastor MJ, Gautier S, Biour M, Massy Z.
    Ann Pharmacother; 2005 Apr 15; 39(7-8):1194-7. PubMed ID: 15956222
    [Abstract] [Full Text] [Related]

  • 32. Drug-related deaths in a university central hospital.
    Juntti-Patinen L, Neuvonen PJ.
    Eur J Clin Pharmacol; 2002 Oct 15; 58(7):479-82. PubMed ID: 12389071
    [Abstract] [Full Text] [Related]

  • 33. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.
    Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM, HARM Study Group.
    Arch Intern Med; 2008 Sep 22; 168(17):1890-6. PubMed ID: 18809816
    [Abstract] [Full Text] [Related]

  • 34. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 22; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 35. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?
    Price JF, Mott AR, Dickerson HA, Jefferies JL, Nelson DP, Chang AC, O'Brian Smith E, Towbin JA, Dreyer WJ, Denfield SW, Goldstein SL.
    Pediatr Crit Care Med; 2008 May 22; 9(3):279-84. PubMed ID: 18446113
    [Abstract] [Full Text] [Related]

  • 36. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D, Camm J, Cook P, Falkai P, Gury C, Hurley R, Johnson G, Piepho R, Vieweg V, Cardiac Safety in Schizophrenia Group.
    Encephale; 2002 May 22; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [Abstract] [Full Text] [Related]

  • 37. Chronic renal disease in Kuwaiti nationals: a prospective study during the past 4 years.
    El-Reshaid W, El-Reshaid K, Kapoor M, Hakim A.
    Ren Fail; 2005 May 22; 27(2):227-33. PubMed ID: 15807190
    [Abstract] [Full Text] [Related]

  • 38. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug 22; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 39. [Surgery of abdominal aorta with horseshoe kidney].
    Lotina SL, Davidović LB, Kostić DM, Velimirović DV, Petrović PLj, Perisić-Savić MV, KovacevićN S.
    Srp Arh Celok Lek; 1997 Aug 22; 125(1-2):36-44. PubMed ID: 17974353
    [Abstract] [Full Text] [Related]

  • 40. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 22; 423():1-336. PubMed ID: 12616288
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.